[Federal Register Volume 65, Number 81 (Wednesday, April 26, 2000)]
[Notices]
[Page 24491]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-10413]



[[Page 24491]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(6) and 552b(c)(9)(B), 
Title 5 U.S.C., as amended. The discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the review 
of applications, and information concerning NCI and/or its contractors, 
the disclosure of which would constitute a clearly unwarranted invasion 
of personal privacy, and the premature disclosure of discussions 
related to personnel and programmatic issues would be likely to 
significantly frustrate the subsequent implementation of 
recommendations.

    Name of Committee: National Cancer Advisory Board and 
Subcommittee on Cancer Centers.
    Dates: June 12-14, 2000.
    Name of Committee: Subcommittee on Cancer Centers.
    Open: June 12, 7:00 p.m. to Recess.
    Agenda: Cancer Centers Support Guideline Update.
    Place: Bethesda Hyatt Regency, One Bethesda Metro Center, 
Bethesda, MD 20814, (301) 657-1234.
    Contact Person: Dr. Brian Kimes, Executive Secretary, Office of 
Centers, Training, and Resources, National Cancer Institute, 
National Institutes of Health, 6116 Executive Boulevard, Suite 700, 
Bethesda, MD 20892, (301) 496-8537.
    Name of Committee: National Cancer Advisory Board.
    Open: June 13, 8:45 a.m. to 3:45 p.m. and June 14, 9:00 a.m. to 
3:00 p.m.
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups, http://deainfo.nci.nik.gov/ADVISORY/boards.htm. Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.
    Closed: June 13, 2000, 4:00 p.m. to Recess.
    Agenda: Review of Grant Applications.
    Place: Building 31, C Wing, 6 Floor, Conference Room 10, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 
20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8022, Bethesda, MD 20892-8327, 
(301) 496-5147.

(Catalogue of Federal Domestic Assistance Program Nos. 92.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394; Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)
    Dated: April 19, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-10413 Filed 4-25-00; 8:45 am]
BILLING CODE 4140-01-M